BioWorld

May 8, 2009

View Archived Issues

Vanda Shares Surge 626% on FDA Approval of Fanapt

Shares in Vanda Pharmaceuticals Inc. rocketed into the stratosphere Thursday on news of the FDA's surprising approval of the company's antipsychotic Fanapt. (BioWorld Today) Read More

HHS Officials Provide More Details on HHS FY 2010 Budget

Read More

Candidate Culprit for Multiple Sclerosis Gray Matter Damage

Read More

Zenobia Takes Up Arms Against Parkinson's, Other CNS Diseases

Read More

Licensing Deal Gives Pharma Firm Majority of Cornerstone

Read More

Financings Roundup

Read More

Other News To Note

Read More

Clinic Roundup

Read More

Earnings Roundup

Read More